BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23039325)

  • 1. Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma.
    Nomoto J; Hiramoto N; Kato M; Sanada M; Maeshima AM; Taniguchi H; Hosoda F; Asakura Y; Munakata W; Sekiguchi N; Maruyama D; Watanabe T; Nakagama H; Takeuchi K; Tobinai K; Ogawa S; Kobayashi Y
    BMC Cancer; 2012 Oct; 12():457. PubMed ID: 23039325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
    Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TNFAIP3 deletion status in classical Hodgkin lymphoma and its relation to Epstein-Barr virus].
    Shi YF; Gao ZF; Liu CL; Li M; Lin DM; Zhou LX; Lai YM; Liu XL; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1060-1064. PubMed ID: 28088970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
    Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
    Giulino L; Mathew S; Ballon G; Chadburn A; Barouk S; Antonicelli G; Leoncini L; Liu YF; Gogineni S; Tam W; Cesarman E
    Blood; 2011 May; 117(18):4852-4. PubMed ID: 21406721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
    Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
    J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.
    Philipp C; Edelmann J; Bühler A; Winkler D; Stilgenbauer S; Küppers R
    Int J Cancer; 2011 Apr; 128(7):1747-50. PubMed ID: 20533286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
    Hirsch B; Grünbaum M; Wagner F; Bi Y; Lucka L; Du MQ; Stein H; Dürkop H
    Histopathology; 2012 May; 60(6B):E19-27. PubMed ID: 22393903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
    Malynn BA; Ma A
    J Exp Med; 2009 May; 206(5):977-80. PubMed ID: 19380636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
    Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
    Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of Hodgkin lymphoma.
    Küppers R
    Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment.
    Paik JH; Go H; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Leuk Lymphoma; 2013 Sep; 54(9):1934-41. PubMed ID: 23327292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
    Lake A; Shield LA; Cordano P; Chui DT; Osborne J; Crae S; Wilson KS; Tosi S; Knight SJ; Gesk S; Siebert R; Hay RT; Jarrett RF
    Int J Cancer; 2009 Sep; 125(6):1334-42. PubMed ID: 19507254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
    Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
    Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.